Clinical Trials Browser

OTHER × Multiple Myeloma × Drugs, Investigational × Clear all

NCT04111107 2024-07-03

Precision Medicine for Patients With Identified Actionable Mutations

Phase 2 Terminated

45 enrolled 13 charts

LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Neoplasms